GRAF FINCKENSTEIN FRIEDRICH Insider Trades

Insider Trading History

Track insider trading activity for GRAF FINCKENSTEIN FRIEDRICH. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $259k 54,691 shares
Last Trade
Jun 05, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$33k 7,813 shares
$4.23
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $664k 140,111 shares
Last Trade
Jun 05, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$16.8k 3,976 shares
$4.23
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $683k 144,087 shares
Last Trade
Jun 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$33k 7,813 shares
$4.23
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $646k 136,274 shares
Last Trade
Jun 01, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$17.7k 4,473 shares
$3.96
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $667k 140,747 shares
Last Trade
Jun 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$34.8k 8,790 shares
$3.96
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $125k 26,369 shares
Last Trade
Jun 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$34.8k 8,790 shares
$3.96
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $278k 58,750 shares
Last Trade
Mar 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$318k 58,750 shares
$5.41
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $296k 62,504 shares
Last Trade
Mar 05, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$143k 31,246 shares
$4.58
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $704k 148,477 shares
Last Trade
Mar 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$143k 31,246 shares
$4.58
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $625k 131,957 shares
Last Trade
Mar 05, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$75.7k 16,520 shares
$4.58
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Mar 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$14.8k 3,907 shares
$3.79
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $167k 35,159 shares
Last Trade
Mar 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$33.3k 8,790 shares
$3.79
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $556k 117,231 shares
Last Trade
Mar 02, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$27k 7,122 shares
$3.79
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $589k 124,353 shares
Last Trade
Mar 02, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$48.1k 12,697 shares
$3.79
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $18.5k 3,907 shares
Last Trade
Dec 02, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$8.34k 3,906 shares
$2.14
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $529k 111,656 shares
Last Trade
Dec 02, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.25k 1,984 shares
$2.14
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $539k 113,640 shares
Last Trade
Dec 02, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$8.34k 3,906 shares
$2.14
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $208k 43,949 shares
Last Trade
Dec 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$19.6k 8,789 shares
$2.23
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $541k 114,198 shares
Last Trade
Dec 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$19.6k 8,789 shares
$2.23
$4.74
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Medical Officer
Holding Value $520k 109,734 shares
Last Trade
Dec 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$9.95k 4,464 shares
$2.23
$4.74

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up